Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

ICUI
ICU Medical Inc
stock NASDAQ

At Close
Aug 21, 2026 3:59:58 PM EDT
182.90USD+0.203%(+0.37)182,320
0.00Bid   0.00Ask   0.00Spread
Pre-market
Aug 21, 2026 8:45:30 AM EDT
183.05USD+0.285%(+0.52)1,017
After-hours
Aug 20, 2026 4:00:30 PM EDT
182.53USD+0.093%(+0.17)0
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 7, 2022
01:03PM EST  The Daily Biotech Pulse: Glaukos Gets FDA Nod, Neurocrine Preannounces Soft Ingrezza Sales, 3 IPOs   Benzinga
Jan 6, 2022
04:30PM EST  ICU Medical Completes the Acquisition of Smiths Medical from Smiths Group plc   PR Newswire
Dec 29, 2021
08:30AM EST  ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will present at the J.P. Morgan 40th Annual Healthcare Conference, held virtually January 10-13, 2022.   GlobeNewswire Inc
Nov 3, 2021
06:28PM EDT  ICU Medical Q3 EPS $2.07 Beats $1.80 Estimate, Sales $336.06M Beat $314.30M Estimate   Benzinga
05:12PM EDT  ICU Medical Q3 EPS $1.43 Vs. $1.16 Year Ago   RTTNews
09:19AM EDT  The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering   Benzinga
09:10AM EDT  Earnings Scheduled For November 3, 2021   Benzinga
Oct 31, 2021
02:24PM EDT  The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline   Benzinga
Oct 22, 2021
12:20PM EDT  Where ICU Medical Stands With Analysts   Benzinga
04:42AM EDT  Keybanc Maintains Overweight on ICU Medical, Lowers Price Target to $280   Benzinga
Oct 13, 2021
08:30AM EDT  ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its third quarter 2021 earnings release and conference call.   GlobeNewswire Inc
Sep 9, 2021
08:35AM EDT  10 Biggest Price Target Changes For Thursday   Benzinga
08:17AM EDT  The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization   Benzinga
07:52AM EDT  Raymond James Maintains Outperform on ICU Medical, Raises Price Target to $286   Benzinga
06:03AM EDT  A Peek Into The Markets: US Stock Futures Fall Ahead Of Jobless Claims, Fed Speakers   Benzinga
04:45AM EDT  Keybanc Maintains Overweight on ICU Medical, Raises Price Target to $302   Benzinga
Sep 8, 2021
03:50PM EDT  Why ICU Medical Shares Surged Today   Benzinga
02:32PM EDT  Mid-Afternoon Market Update: Kadmon Surges Following Acquisition News; UiPath Shares Drop   Benzinga
02:29PM EDT  Mid-Day Market Update: Crude Oil Rises 1%; REV Group Shares Plummet   Benzinga
11:05AM EDT  Shares of ICU Medical, Inc. (ICUI) are jumping over 30% on Wednesday morning after the company announced a deal to buy UK-based Smiths Group plc's medical division for $2.35 billion.   RTTNews
10:16AM EDT  Mid-Morning Market Update: Markets Mixed; Korn Ferry Reports Upbeat Q1 Results   Benzinga
07:35AM EDT  Smiths Group Divests Its Medical Division To ICU Medical In $2.4B Deal   Benzinga
04:02AM EDT  ICU Medical, Inc., a pure-play infusion therapy company, is recalling one lot of Aminosyn II, 15%, An Amino Acid Injection, Sulfite Free intravenous or IV solution to the hospital/user level, the U.S. Food and Drug Administration said in a statement.   RTTNews
02:15AM EDT  The addition of Smiths Medical syringe and ambulatory infusion devices, vascular access, and vital care products intoICU Medical creates a leading infusion therapy company with a stronger global reach   GlobeNewswire Inc
Sep 3, 2021
02:56PM EDT  Acid Injection, Sulfite Free IV Solution Due to the Presence of Particulate Matter   PR Newswire
Aug 6, 2021
04:48AM EDT  Keybanc Maintains Overweight on ICU Medical, Lowers Price Target to $225   Benzinga
Aug 5, 2021
07:26AM EDT  Raymond James Maintains Outperform on ICU Medical, Lowers Price Target to $220   Benzinga
Aug 4, 2021
04:54PM EDT  ICU Medical Narrows FY21 Adj. EPS Guidance From $6.50-$7.20 To $6.80-$7.20 vs $6.93 Estimate   Benzinga
04:53PM EDT  ICU Medical Q2 Adj. EPS $1.88 Beats $1.64 Estimate, Sales $321.70M Beat $305.43M Estimate   Benzinga
04:42PM EDT  ICU Medical Q2 EPS $1.31 Vs. $0.88 Year Ago   RTTNews
04:05PM EDT  ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced financial results for the quarter ended June 30, 2021.   GlobeNewswire Inc
04:10AM EDT  Earnings Scheduled For August 4, 2021   Benzinga
Aug 3, 2021
10:52AM EDT  Earnings Outlook For ICU Medical   Benzinga
Jul 15, 2021
08:00AM EDT  ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its second quarter 2021 earnings release and conference call.   GlobeNewswire Inc
May 6, 2021
05:20PM EDT  ICU Medical Q1 GAAP EPS $1.09 Vs $0.78 Last Year   RTTNews
04:54PM EDT  ICU Medical Q1 EPS $1.62 Beats $1.50 Estimate, Sales $318.00M Beat $300.90M Estimate   Benzinga
07:49AM EDT  The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom   Benzinga
04:17AM EDT  Earnings Scheduled For May 6, 2021   Benzinga
Apr 15, 2021
08:00AM EDT  ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its first quarter 2021 earnings release and conference call.   GlobeNewswire Inc
Mar 18, 2021
08:30AM EDT  ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will participate in a virtual fireside chat at the KeyBanc Life Sciences & MedTech Investor Forum at 7:45 a.m. PT (10:45 a.m. ET) on Tuesday, March 23, 2021.   GlobeNewswire Inc
Feb 26, 2021
08:12AM EST  Raymond James Maintains Outperform on ICU Medical, Raises Price Target to $245   Benzinga
Feb 25, 2021
04:48PM EST  ICU Medical Q4 EPS $1.21 Vs. $0.96 Year Ago   RTTNews
04:32PM EST  ICU Medical Sees FY21 Adj. EPS $6.50-$7.20, Adj. EBITDA $245M-$265M   Benzinga
04:32PM EST  ICU Medical Q4 Adj. EPS $1.77 Beats $1.51 Estimate, Sales $320.50M Beat $295.33M Estimate   Benzinga
08:08AM EST  The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants   Benzinga
04:03AM EST  Earnings Scheduled For February 25, 2021   Benzinga
Feb 24, 2021
08:30AM EST  ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will present at the Raymond James 42nd Annual Institutional Investors Conference, held virtually March 1-3, 2021.   GlobeNewswire Inc
Feb 4, 2021
08:00AM EST  ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its fourth quarter and fiscal year 2020 earnings release and conference call.   GlobeNewswire Inc
Feb 2, 2021
08:16AM EST  ICU Medical's Plum 360(tm) Infusion System Receives First-Ever Best in KLAS   PR Newswire
Jan 8, 2021
04:43AM EST  KeyBanc Maintains Overweight on ICU Medical, Raises Price Target to $236   Benzinga
Jan 5, 2021
07:30AM EST  ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will present at the J.P. Morgan 39th Annual Healthcare Conference, held virtually January 11-14, 2021.   GlobeNewswire Inc
Nov 6, 2020
04:04AM EST  KeyBanc Maintains Overweight on ICU Medical, Raises Price Target to $222   Benzinga
Nov 5, 2020
05:12PM EST  ICU Medical Raises FY20 Adj. EPS Guidance From $5.95-$6.65 To $6.65-$7 vs $6.40 Estimate, Narrows Adj. EBITDA From $230M-$250M To $235M-$245M   Benzinga
05:11PM EST  ICU Medical Q3 Adj. EPS $1.65 Beats $1.31 Estimate, Sales $318.60M Beat $284.70M Estimate   Benzinga
05:05PM EST  ICU Medical Q3 EPS $1.16 Vs. $1.24 Year Ago   RTTNews
07:54AM EST  The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping   Benzinga
04:34AM EST  Earnings Scheduled For November 5, 2020   Benzinga
Nov 1, 2020
09:40AM EST  The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings   Benzinga
Oct 15, 2020
07:30AM EDT  ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its third quarter 2020 earnings release and conference call.   GlobeNewswire Inc
Sep 8, 2020
07:30AM EDT  ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will present virtually at the Morgan Stanley 18th Annual Global Healthcare Conference, held on September 14-18, 2020.   GlobeNewswire Inc
Sep 2, 2020
08:12AM EDT  10 Biggest Price Target Changes For Wednesday   Benzinga
04:43AM EDT  KeyBanc Maintains Overweight on ICU Medical, Raises Price Target to $218   Benzinga
Aug 11, 2020
08:09AM EDT  Raymond James Maintains Outperform on ICU Medical, Lowers Price Target to $210   Benzinga
Aug 10, 2020
05:03PM EDT  ICU Medical Inc. (ICUI) Monday reported second-quarter net income of $18.9 million or $0.88 per share, down from $22.8 million or $1.06 per share last year.   RTTNews
04:21PM EDT  ICU Medical Q2 EPS $1.65 Beats $1.24 Estimate, Sales $303.40M Beat $276.70M Estimate   Benzinga
04:18PM EDT  ICU Medical Q2 GAAP EPS $0.88 Vs $1.06 Last Year   RTTNews
04:06PM EDT  ICU Medical Enters Into Long-Term Agreement With Grifols To Distribute A Full Line Of Non-PVC/Non-DEHP IV Containers For 0.9% Sodium Chloride Injection, USP To Customers In The United States   Benzinga
04:06PM EDT  ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced financial results for the quarter ended June 30, 2020.   GlobeNewswire Inc
04:00PM EDT  Long-Term U.S. Distribution Agreement with Grifols for Certain Core IV Solution Products   PR Newswire
04:10AM EDT  Earnings Scheduled For August 10, 2020   Benzinga
Jul 15, 2020
07:30AM EDT  ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its second quarter 2020 earnings release and conference call.   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC